leadf
logo-loader
viewPerrigo Company

Perrigo shares rise on investor disclosure, Taro Pharma falls on probe

Perrigo Company shares advanced more than 7% on Monday after investor Starboard Value disclosed taking a 4.6% stake in the drug maker, according to the Wall Street Journal. But Taro Pharma has a probe to contend with

6862528051_212f743008_o_opt_opt_opt.jpg
Perrigo and Taro go in opposite directions

Perrigo Company (NYSE:PRGO) shares advanced more than 7% on Monday after investor Starboard Value disclosed taking a 4.6% stake in the drug maker, according to the Wall Street Journal.

The paper said the activist investment firm sent Perrigo a letter over the weekend saying it had failed to achieve performance targets and that it had been distracted fending off a takeover bid from Mylan (NASDAQ:MYL) in 2015.

Starboard said Perrigo should consider offloading its prescription drug business Rx Pharmaceuticals, which analysts believe would then open up strategic options for its consumer drug operation.

Proactiveinvestors reported Perrigo as a possible takeout target for Reckitt Benckiser (LON:RB. in July. Read more.

Perrigo shares rise 7.3% to $95.22 on Monday.

Meanwhile, Taro Pharmaceuticals (NYSE:TARO) shares dropped by 4% to $11.41 after Taro was subpoenaed by the US Justice Department, along with two of its senior officers, in connection with a federal investigation into generic drug pricing.

Quick facts: Perrigo Company

Price: 45.62 USD

NYSE:PRGO
Market: NYSE
Market Cap: $6.23 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Trump Vs Biden debate: Market reaction, corporate support and future predictions

Neil Wilson from Markets.com joins Proactive London's Katie Pilbeam following the U.S. President Donald Trump and Democratic rival Joe Biden debate on Thursday night. With 47 million Americans already voted - do the markets even care? Wilson says there was 'no killer blow' which would explain...

1 day, 9 hours ago

2 min read